Survey Cardiology-Evaluation of US ICD Market_SEP2006September 2006
Deliverable: Raw Data and PowerPoint Presentation
Primary Objective: To assess the impact of recent product recall activity on the Implantable Cardioverter Defibrillator (ICD) market in the United States
Objectives:
- Gauge current and future ICD implant volume among U.S. electrophysiologists
- Understand current and future product mix among three manufacturers (Medtronic, Guidant, and St. Jude)
- Assess patient referral patterns for ICD therapy
- Measure the effect of Medtronic campaign on patient referrals and overall market (initial implant) growth
Products Highlighted:
Topics:
- ICD Implant Volume
- Current and Anticipated Product Mix (Medtronic, Guidant, St. Jude) - Effect of Recalls on Use of Guidant Devices
- Medtronic Campaign Assessment
- Reimbursement and Patient Data
Screening Criteria:
- 52 electrophysiologists from across the United States
- Board certified or board eligible in electrophysiology
- Have been in practice between 2 and 30 years
- Spend at least 75% of their professional time in clinical practice
- Perform an average of 10 ICD implants per month